Home Health Costs Topics

Health Costs

The MIDTERMS

Democrats Hold a Nearly 2-to-1 Advantage Over Republicans on Handling the Cost of Health Care

Poll: Cost of Health Care and Gas Top Voters’ Midterm Concerns; Democrats Hold Significant Advantage on Health Care Costs and Cost of Living 

With the 2026 midterms about a month away, health care costs remain tied with gas as voters’ top midterm concerns and the Democrats hold a clear edge over the Republicans Party on who voters trust to handle many top electoral issues, including the cost of health care and the cost of living. Two-thirds of U.S. adults now favor Medicare-for-all, a new high in KFF Polling, but support shifts when competing claims from critics and proponents are heard.

New and noteworthy

Health System Tracker

Is This A Healthcare Economy?

Health care employment has grown faster than other sectors of the economy, with jobs in physician offices, hospitals, outpatient care centers, home health, and other settings increasing over the past year even as the rest of the job market plateaued. 

U.S. Health Spending Is Expected to Reach $9 Trillion by 2034

How Much is Health Spending Expected to Grow?

This chart collection explores how much health spending is expected to grow in the coming years, with a look at growth in prescription drug spending, out-of-pocket spending, and related trends.

How TrumpRx Brand-Name Drug Prices Compare

TrumpRx prices for brand-name drugs are about as likely to be higher as lower compared to average prices in other wealthy countries, according to an analysis that compares 32 brand-name drugs.

Latest News

More KFF Health News

Stay informed.

Get KFF's latest on Health Costs

Stay informed.

Get KFF's latest on Health Costs

View the Latest: Health Costs

Filter

List Grid

811-820 of 1,626 results

  • Poll: Public Says Drug Companies Have More Influence in Washington than the NRA

    News Release

    Democrats Split on Whether to Fix the ACA or Push for a National Health Plan; Few Democratic Voters Say a National Health Plan is Their Top Issue for the Midterms As policymakers weigh strategies to address the high cost of prescription drugs, the latest Kaiser Health Tracking Poll finds that a large majority of the public (72%) view pharmaceutical companies as having too much influence in Washington – more than say the same about the…

  • New Interactive Tool Allows Users to Explore Trends in US Health Spending and Share Custom-Made Charts

    News Release

    A new interactive tool on the Peterson-Kaiser Health System Tracker allows users to analyze the most up-to-date data on U.S. health spending, then build, display and share the charts they create. Developed by analysts at the Kaiser Family Foundation, the Health Spending Explorer helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician & clinic care, and prescription drugs.…

  • Why Low Growth in Health Costs Still Stings

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman shows how rising deductibles have eclipsed growth in wages and discusses why that may be the main reason people think costs have been continuing to rise rapidly when instead, growth has slowed. All previous columns by Drew Altman are available online.   

  • How to Think About Higher Growth in Health-Care Spending

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman explains that just as we should not have expected historically low rates of health spending increases to continue, we should not dramatize a return to higher rates in coming years.

  • The Connection Between Health Coverage and Income Security

    From Drew Altman

    In this column in The Wall Street Journal's Think Tank, Drew Altman shows how expanding health coverage and improving economic security for working Americans are connected even though they are often part of separate policy debates.

  • Visualizing Health Policy: Recent Trends in Employer-Sponsored Insurance

    News Release

    This Visualizing Health Policy takes a look at recent trends in employer-sponsored insurance, including average premium increases for workers with family coverage, the average yearly cost of premiums for single and family coverage and how those costs have increased in the past decade, along with the prevalence of health promotion programs (such as wellness programs) offered by large firms. It also looks at differences in premium and worker contributions at firms with many lower-wage workers…

  • What is behind the recent slowdown in health spending?

    Feature

    This slideshow charts the recent slowdown in health spending in the United States and other industrialized nations. Some possible causes include economic factors and structural changes to the U.S. health system, such as higher cost sharing in private health insurance and lower payments to providers by Medicare and other public programs.

  • How do mortality rates in the U.S. compare to other countries?

    Feature

    This slideshow compares mortality rates in the United States and other industrialized countries for seven major causes of death. The data show that U.S. mortality rates for circulatory diseases and cancer have fallen in the past 30 years, driving a decline in the nation's overall rate. However, mortality rates for leading causes of death other than cancer are higher in the United States than the average for comparable countries.

  • What Drives Spending and Utilization on Medicaid Drug Benefits in States?

    Issue Brief

    With the approval of new specialty drugs, such as the Hepatitis C treatments Sovaldi and Harvoni, states are mindful that the cost the Medicaid prescription drug benefit could increase. To achieve savings, and improve management and health outcomes, it is important to understand which drugs are most frequently prescribed and which drive spending. Using state drug utilization data provided through the Medicaid Drug Rebate Program, as well as an industry drug database, this issue brief…